By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AcelRx Pharmaceuticals 

575 Chesapeake Drive

Redwood City  California  94063  U.S.A.
Phone: 650-216-3500 Fax: 650-216-6500




Company News
AcelRx (ACRX) To Present At Two Upcoming Investor Events In February 2/3/2016 9:26:20 AM
AcelRx (ACRX) Announces Presentation Of Phase 3 Sufentanil Sublingual 30 Mcg Tablet (ARX-04) Data At The European Congress Of Ambulatory Surgery 1/21/2016 6:09:44 AM
AcelRx (ACRX) Announces Anticipated 2016 Milestones 1/11/2016 12:04:34 PM
AcelRx (ACRX) Announces Anticipated 2016 Milestones 1/11/2016 12:00:46 PM
AcelRx (ACRX) Completes Protocol Review With FDA And Plans To Initiate Phase 3 Open-Label Study (IAP312) For Zalviso In 1Q 2016 1/8/2016 6:21:57 AM
AcelRx (ACRX) Receives Notice Of Eligibility For Centralized Review Of ARX-04 From European Medicines Agency 12/23/2015 10:20:48 AM
AcelRx (ACRX) Conducts Pre-NDA Meeting With FDA For ARX-04 12/14/2015 6:33:45 AM
AcelRx (ACRX) To Present At Piper Jaffray 27th Annual Healthcare Conference 11/23/2015 7:35:59 AM
AcelRx (ACRX) Announces Sublingual Sufentanil Data Presentation At The American Society Of Regional Anesthesia And Pain Medicine Meeting 11/19/2015 7:19:14 AM
AcelRx (ACRX) To Present At Jefferies and Co. 2015 Global Healthcare Conference 11/10/2015 8:46:50 AM